Overview
- Peter Marks, the FDA's top vaccine official, resigned after refusing to support Robert F. Kennedy Jr.'s requests for nonexistent data linking vaccines to severe side effects.
- Kennedy announced plans to restructure federal health agencies, including 10,000 layoffs and centralization of FDA and CDC functions.
- The FDA missed a critical vaccine approval deadline for Novavax's COVID-19 vaccine, reportedly due to decisions involving new FDA Commissioner Marty Makary.
- Kennedy's support for a study on the debunked vaccine-autism link, led by a controversial figure, has intensified scrutiny of his leadership.
- A measles outbreak in Texas and New Mexico has raised alarm about declining vaccination rates and the potential public health impact of Kennedy's policies.